This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nagaraj, S. Articles by Gabrilovich, D. I. Search for Related Content PubMed PubMed Citation Articles by Nagaraj, S. Articles by Gabrilovich, D. I. Related Collections Tumor Biology Tumor Biology: Inflammation and Immune Escape Cancer Immunology: Innate Immunity

Tumor Escape Mechanism Governed by Myeloid-Derived Suppressor Cells

H. Lee Moffitt Cancer Center, University of South Florida, Tampa, Florida

Requests for reprints: Dmitry Gabrilovich, H. Lee Moffitt Cancer Center, University of South Florida, MRC-2, Room 2067, 12902 Magnolia Drive, Tampa, FL 33612. Phone: 813-903-6863; Fax: 813-632-1328; E-mail: dmitry.gabrilovich{at}moffitt.org.

Key Words: immune suppression • T cells • tumor immunology

T-cell nonresponsiveness is a critical factor in immune escape and myeloid-derived suppressor cells play a major role in organizing this phenomenon. Recent findings indicate that myeloid-derived suppressor cells can induce antigen-specific CD8⁺ T-cell tolerance through a posttranslation mechanism which involves modification (nitration) of CD8 and the T-cell receptor itself on the T-cell surface. Elucidation of this mechanism of T-cell tolerance offers new opportunities for therapeutic corrections of immune escape in cancer. [Cancer Res 2008;68(8):2561–63]

This article has been cited by other articles:

				S. Kimpfler, A. Sevko, S. Ring, C. Falk, W. Osen, K. Frank, M. Kato, K. Mahnke, D. Schadendorf, and V. Umansky Skin Melanoma Development in ret Transgenic Mice Despite the Depletion of CD25+Foxp3+ Regulatory T Cells in Lymphoid Organs J. Immunol., November 15, 2009; 183(10): 6330 - 6337. [Abstract] [Full Text] [PDF]

				A. Ohta, A. Ohta, M. Madasu, R. Kini, M. Subramanian, N. Goel, and M. Sitkovsky A2A Adenosine Receptor May Allow Expansion of T Cells Lacking Effector Functions in Extracellular Adenosine-Rich Microenvironments J. Immunol., November 1, 2009; 183(9): 5487 - 5493. [Abstract] [Full Text] [PDF]

				P. Presicce, S. Giannelli, A. Taddeo, M. L. Villa, and S. Della Bella Human defensins activate monocyte-derived dendritic cells, promote the production of proinflammatory cytokines, and up-regulate the surface expression of CD91 J. Leukoc. Biol., October 1, 2009; 86(4): 941 - 948. [Abstract] [Full Text] [PDF]

				F. Colotta, P. Allavena, A. Sica, C. Garlanda, and A. Mantovani Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis, July 1, 2009; 30(7): 1073 - 1081. [Abstract] [Full Text] [PDF]

				F. Zhao, C. Falk, W. Osen, M. Kato, D. Schadendorf, and V. Umansky Activation of p38 Mitogen-Activated Protein Kinase Drives Dendritic Cells to Become Tolerogenic in Ret Transgenic Mice Spontaneously Developing Melanoma Clin. Cancer Res., July 1, 2009; 15(13): 4382 - 4390. [Abstract] [Full Text] [PDF]

				T. Hagemann, S. K. Biswas, T. Lawrence, A. Sica, and C. E. Lewis Regulation of macrophage function in tumors: the multifaceted role of NF-{kappa}B Blood, April 2, 2009; 113(14): 3139 - 3146. [Abstract] [Full Text] [PDF]

				I. L. King, T. L. Dickendesher, and B. M. Segal Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease Blood, April 2, 2009; 113(14): 3190 - 3197. [Abstract] [Full Text] [PDF]

				T. H. Schreiber, V. V. Deyev, J. D. Rosenblatt, and E. R. Podack Tumor-Induced Suppression of CTL Expansion and Subjugation by gp96-Ig Vaccination Cancer Res., March 1, 2009; 69(5): 2026 - 2033. [Abstract] [Full Text] [PDF]

				G. C. Prendergast Risk Factors for Cancer: From Cell to Microenvironment Cancer Reviews Online Content, May 1, 2008; 2008(5): 9 - 9. [Full Text] [PDF]